A detailed history of Vinva Investment Management LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Vinva Investment Management LTD holds 15,266 shares of VCYT stock, worth $604,380. This represents 0.03% of its overall portfolio holdings.

Number of Shares
15,266
Holding current value
$604,380
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$21.0 - $35.25 $320,586 - $538,126
15,266 New
15,266 $744 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.83B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Vinva Investment Management LTD Portfolio

Follow Vinva Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vinva Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Vinva Investment Management LTD with notifications on news.